Stocktwits on MSN
IBRX stock rises 3% pre-market: ImmunityBio reports breakthrough in NK cell therapy production
Shares of ImmunityBio (IBRX) gained more than 3% in pre-market trading on Friday, after the pharmaceutical firm announced on Friday the completion of key manufacturing engineering programs supporting ...
As far as economic reports go, the good news just keeps on coming. Seemingly running on a separate track from investor fears about AI’s future role in the economy, today’s latest inflation read came ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results